How South Korea turbocharged specialty syringe production for COVID-19 vaccines

Under fire in local media for not doing enough to secure COVID-19 vaccines, South Korea's government had been reviewing options to accelerate shipments and gain more supply. Engineering a jump in LDS syringe output was an opportunity to be seized, it concluded. The niche products were suddenly in huge demand globally after it became apparent they could be used to squeeze out a sixth dose from vials of Pfizer Inc (PFE.N) and BioNTech's (22UAy.DE) newly approved COVID-19 vaccine compared to five doses with a standard syringe. 'It had come to our attention that Pfizer was looking for LDS syringes...using LDS syringes automatically boosts vaccine volume by 20%,' Park told Reuters.